Package 63323-132-12
Brand: mitoxantrone
Generic: mitoxantrone hydrochloridePackage Facts
Identity
Package NDC
63323-132-12
Digits Only
6332313212
Product NDC
63323-132
Description
1 VIAL, MULTI-DOSE in 1 BOX (63323-132-12) / 12.5 mL in 1 VIAL, MULTI-DOSE
Marketing
Marketing Status
Brand
mitoxantrone
Generic
mitoxantrone hydrochloride
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "0b47411d-1c42-4241-9301-4ecc3197470c", "openfda": {"unii": ["U6USW86RD0"], "rxcui": ["197989"], "spl_set_id": ["fcb8ef8a-f770-4416-8fc5-fa01d98c8eee"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (63323-132-10) / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "63323-132-10", "marketing_start_date": "20060411"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (63323-132-12) / 12.5 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "63323-132-12", "marketing_start_date": "20060411"}, {"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 BOX (63323-132-15) / 15 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "63323-132-15", "marketing_start_date": "20060411"}], "brand_name": "Mitoxantrone", "product_id": "63323-132_0b47411d-1c42-4241-9301-4ecc3197470c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "63323-132", "generic_name": "MITOXANTRONE HYDROCHLORIDE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Mitoxantrone", "active_ingredients": [{"name": "MITOXANTRONE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA077496", "marketing_category": "ANDA", "marketing_start_date": "20060411", "listing_expiration_date": "20261231"}